The good and evil of complement activation in HIV-1 infection
- PMID: 20228834
- PMCID: PMC4002684
- DOI: 10.1038/cmi.2010.8
The good and evil of complement activation in HIV-1 infection
Abstract
The complement system, a key component of innate immunity, is a first-line defender against foreign pathogens such as HIV-1. The role of the complement system in HIV-1 pathogenesis appears to be multifaceted. Although the complement system plays critical roles in clearing and neutralizing HIV-1 virions, it also represents a critical factor for the spread and maintenance of the virus in the infected host. In addition, complement regulators such as human CD59 present in the envelope of HIV-1 prevent complement-mediated lysis of HIV-1. Some novel approaches are proposed to combat HIV-1 infection through the enhancement of antibody-dependent complement activity against HIV-1. In this paper, we will review these diverse roles of complement in HIV-1 infection.
References
-
- Qin X, Gao B. The complement system in liver diseases. Cell Mol Immunol. 2006;3:333–340. - PubMed
-
- Zhou X, Hu W, Qin X. The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy. Oncologist. 2008;13:954–966. - PubMed
-
- Morgan BP, Berg CW, Harris CL. “Homologous restriction” in complement lysis: roles of membrane complement regulators. Xenotransplantation. 2005;12:258–265. - PubMed
-
- Morgan BP. Regulation of the complement membrane attack pathway. Crit Rev Immunol. 1999;19:173–198. - PubMed
-
- Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344:1058–1066. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous